ArticleJournal of clinical medicine2021

One-Year Outcome of Glycoprotein IIb/IIIa Inhibitor Therapy in Patients with Myocardial Infarction-Related Cardiogenic Shock.

Krzysztof Myrda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.